About Cancer Commons
Cancer Commons aims to provide patients and their physicians with the knowledge needed to select the best available therapies and trials, and to continuously update that knowledge based on each patient’s response.
Marty Tenenbaum is a renowned computer scientist and cancer warrior. After surviving stage IV melanoma, he set out to create a ‘commons’ built around diagnoses, biomarkers, treatments, and outcomes for patients who fall outside the standard of care.
Our eminent Board of Directors, Advisory Boards, and Editorial Boards include past presidents of ASCO and AACR, editors of Science and JAMA, as well as leading experts in cancer research, drug development, treatment, biocomputation, informatics, ethics, and patient advocacy.
Check out what’s happening at Cancer Commons, and what others are saying about us.
By tightly integrating research and care around patient treatments and outcomes, rapid learning communities seek to provide each patient with the best possible outcome, while dramatically accelerating the development of promising investigational drugs.
Data is the lifeblood of science. Only by pooling massive datasets generated by new technologies, and untapped data points in electronic health records, case reports, and clinical trial databases, can we hope to find answers with the necessary speed, precision, and urgency to help today’s patients.
Cancer Commons publishes expert-curated consensus models of different cancer types. The rapid learning process will continually test, refine, and extend these models based on new laboratory and clinical findings.
Our core staff, based in Palo Alto, CA, is a small, eclectic group of creative thinkers with impressive track records at transforming their fields. We’re driven by a shared sense of urgency with patients who have exhausted all other options.
Please feel free to download our 501(c)3 letter of determination for your records.